A detailed history of Corient Capital Partners, LLC transactions in Viatris Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 12,837 shares of VTRS stock, worth $166,881. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,837
Previous 10,517 22.06%
Holding current value
$166,881
Previous $110,000 21.82%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $19,673 - $25,821
2,320 Added 22.06%
12,837 $134,000
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $17,074 - $21,055
-1,716 Reduced 14.03%
10,517 $110,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $12,262 - $19,250
-1,250 Reduced 9.27%
12,233 $133,000
Q4 2021

Feb 11, 2022

SELL
$12.09 - $14.68 $16,865 - $20,478
-1,395 Reduced 9.38%
13,483 $182,000
Q3 2021

Nov 16, 2021

SELL
$13.25 - $15.13 $19,689 - $22,483
-1,486 Reduced 9.08%
14,878 $202,000
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $212,241 - $264,278
16,364 New
16,364 $234,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $147,668 - $201,455
-10,866 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $155,383 - $203,628
10,866 New
10,866 $204,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.